Bridging Innovation Research with Clinical Application: Clinical Trials at the Institute of Hematology &#x00026; Blood Diseases Hospital, Chinese Academy of Medical Sciences

Xiaochen Wang; Lijun Liu

doi:10.1055/s-0044-1788572

PDF(127 KB)

Global Medical Genetics ›› 2024, Vol. 11 ›› Issue (03) : 225-226. DOI: 10.1055/s-0044-1788572

Letter to the Editor

research-article

Bridging Innovation Research with Clinical Application: Clinical Trials at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences

Xiaochen Wang¹^,² ,
Lijun Liu¹^,²

Author information +

History +

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾

Xiaochen Wang, Lijun Liu. Bridging Innovation Research with Clinical Application: Clinical Trials at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences. Global Medical Genetics, 2024, 11(03): 225‒226 https://doi.org/10.1055/s-0044-1788572

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Sun M, Yin Q, Liang Y, et al. Ivosidenib in Chinese patients with relapsed or refractory isocitrate dehydrogenase 1 mutated acute myeloid leukemia: a registry study. Blood Sci 2024; 6(03) e00196

[2]	An G, Ge Z, Jing H, et al. Subcutaneous daratumumab in Chinese patients with relapsed or refractory multiple myeloma: an open-label, multicenter, phase 1 study (MMY1010). Blood Sci 2024; 6(03) e00193